Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/PYC stock hub

AIM/PYC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/PYCis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.5M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/PYC

In the news

Latest news · AIM/PYC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-119.7

P25 -54.2P50 2.1P75 13.7

ROIC-82.2

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/PYC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

183

Groups with data

Currency

GBP

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	10
Employees Change	-1%
Employees Change Percent	-9.09
Enterprise value	GBX 2.2M
Exchange	London Stock Exchange AIM
Financial currency	GBP
First seen	2026-05-10
Industry	Biotechnology
Isin	GB00BDR6W943
Last refreshed	2026-05-10
Market cap	GBX 2.5M
Price	GBX 0.55
Price currency	GBX
Rev Per Employee	100,815.6x
Sector	Healthcare
Sic	2836
Symbol	aim/PYC
Website	https://www.physiomics.co.uk

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-19.47%
EV Earnings	-4.61x
EV/FCF	-4.76x
EV/Sales	2.22x
FCF yield	-18.86%
P/B ratio	6.34x
P/S ratio	2.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-52.91%
EBITDA Margin	-51.91%
Gross margin	-50.89%
Gross Profit	GBX -513,077
Net Income	GBX -485,254
Net Income Growth Years	1%
Pretax Margin	-52.99%
Profit Margin	-48.13%
Profit Per Employee	GBX -48,525
ROA	-61.62
Roa5y	-38.66
ROCE	-135.7
ROE	-119.7
Roe5y	-67.86
ROIC	-82.21

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-18%
Cagr15y	-26.82%
Cagr1y	14.59%
Cagr20y	-21.89%
Cagr3y	-43.18%
Cagr5y	-38.79%
EPS Growth Quarters	2
EPS Growth Years	2
Revenue Growth	85.81x
Revenue Growth Q	49.15x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	20.9x
Revenue Growth5 Y	10.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 1.86
Assets	GBX 558,000
Cash	GBX 257,000
Current Assets	GBX 545,000
Current Liabilities	GBX 165,000
Equity	GBX 393,000
Liabilities	GBX 165,000
Long Term Assets	GBX 13,000
Long Term Liabilities	GBX 0
Net Cash	GBX 257,000
Net Cash By Market Cap	GBX 10.31
Net Cash Growth	-4.46%
Net Debt Equity	GBX -0.65
Tangible Book Value	GBX 390,000
Tangible Book Value Per Share	GBX 0
WACC	9.45

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.3
Net Working Capital	GBX 123,000
Quick ratio	3.3
Working Capital	GBX 380,000
Working Capital Turnover	GBX 2.59

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-72.43%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-86.25%
1Y total return	14.58%
200-day SMA	0.42
3Y total return	-81.67%
50-day SMA	0.48
50-day SMA vs 200-day SMA	50over200
5Y total return	-91.41%
All Time High	275
All Time High Change	-99.8%
All Time High Date	2005-02-15
All Time Low	0.25
All Time Low Change	117.82%
All Time Low Date	2025-12-12
ATR	0.07
Beta	0.95
Beta1y	0.61
Beta2y	0.07
Ch YTD	92.98
High	0.6
High52	0.8
High52 Date	2026-02-13
High52ch	-31.16%
Low	0.5
Low52	0.25
Low52 Date	2026-01-19
Low52ch	117.82%
Ma50ch	15.42%
Price vs 200-day SMA	29.47%
RSI	63.6
RSI Monthly	41.6
RSI Weekly	59.38
Sharpe ratio	0.68x
Sortino ratio	1.52
Total Return	-72.43%
Tr YTD	92.98
Tr15y	-99.08%
Tr1m	20.88%
Tr1w	10%
Tr3m	4.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -533,390
Operating margin	-52.91

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	325,982,504%
Shares Insiders	27.49%
Shares Institutions	55.52%
Shares Out	453,208,718
Shares Qo Q	9.83%
Shares Yo Y	72.43%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX -473,250
Average Volume	6,340,188.35x
Bv Per Share	0
CAPEX	GBX -4,935
Ch10y	-86.25
Ch15y	-99.08
Ch1m	20.88
Ch1w	10
Ch1y	14.58
Ch20y	-99.29
Ch3m	4.76
Ch3y	-81.67
Ch5y	-91.41
Ch6m	32.53
Change	10%
Change From Open	4.76
Close	0.5
Days Gap	5
Depreciation Amortization	10,063
Dollar Volume	3,309,076.7
Earnings Date	2026-05-15
EBIT	GBX -533,390
EBITDA	GBX -523,327
EPS	GBX -0
F Score	3
FCF	GBX -470,078
FCF EV Yield	-21.03x
FCF Per Share	GBX -0
Financing CF	456,726
Fiscal Year End	June
Founded	2,001
Income Tax	GBX -49,015
Investing CF	-3,413
Is Primary Listing	1
Last Earnings Date	2025-12-04
Last Report Date	2025-12-31
Last Split Date	2016-12-19
Last Split Type	Reverse
Ma150	0.42
Ma150ch	32.31%
Ma20	0.5
Ma20ch	10.73%
Net CF	-11,830
Next Earnings Date	2026-05-15
Open	0.53
Position In Range	50
Ppne	10,000
Price Date	2026-05-08
Ptbv Ratio	6.39
Relative Volume	0.95x
Revenue	1,008,156x
SBC By Revenue	0.31x
Share Based Comp	3,172
Tax By Revenue	-4.86x
Tr20y	-99.29%
Tr6m	32.53%
Volume	6,016,503
Z Score	-15.92

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/PYC pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/PYC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/PYC?

Insider, institutional, and short-interest positioning.

Institutional ownership

+55.5%

Share of float held by funds and institutions

Insider ownership

+27.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+72.4%

Negative means the company is buying back shares.

Technical

AIM/PYC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.6

Neutral momentum band

Price vs 200-day MA

+29.5%

50/200-day relationship not available

Beta (5Y)

0.95

Moves roughly with the market

Sharpe ratio

0.68

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/PYC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/PYC stock rating?

aim/PYC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/PYC analysis?

The full report lives at /stocks/aim/PYC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/PYC?

The latest report frames aim/PYC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/PYC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.